Brian O Mahony/X
Apr 24, 2026, 14:29
Brian O Mahony: Clinical Management of Emicizumab and Rebalancing Agents
Brian O Mahony, CEO of Irish Haemophilia Society, former President of WFH and EHC, shared a post on X:
”Young WFH Congress 2026.
Table illustrating switching,bleed management,surgical management and washout periods for Emicizumab and the 3 rebalancing agents.”
Other posts featuring Brian O Mahony on Hemostasis Today.
-
May 15, 2026, 15:48Elyse Moritz: First Large-Scale Study on Combined Neonatal Alloimmune Neutropenia and Thrombocytopenia
-
May 15, 2026, 15:46Alexandre Becker: Clinical Importance of Neonatal Thrombocytopenia in Newborns
-
May 15, 2026, 15:42Sula Limei Xu: Expanding Access to Specialty Coagulation Reagents
-
May 15, 2026, 15:42Salih Ehsan: With Thalassemia Children on World Thalassemia Day – 8 May 2026
-
May 15, 2026, 15:33Ney Carter Borges: Wine, Moderation, and Cardiometabolic Health
-
May 15, 2026, 15:33Veronica Sanchez: Women’s Health Month – Supporting the Well-Being of the Women We Love
-
May 15, 2026, 15:26Abdallah Othman։ The Hidden Pattern of Cardiac Amyloidosis in HFpEF
-
May 15, 2026, 15:19Tareq Abadl: Did You Know One Blood Donation Can Be Divided Into Tiny ‘Baby-Sized’ Transfusions?
-
May 15, 2026, 15:15ISBT: The Universal Language of Safe Blood Transfusion – Ali AlBahar